<DOC>
	<DOCNO>NCT01182259</DOCNO>
	<brief_summary>Tuberculosis remain one large health problem world today . Multidrug therapy necessary cure tuberculosis patient prevent selection drug-resistant mutant , however , may increase incidence side effect course treatment . These side effect may mild well fatal . A severe side effect one anti-TB drug , influence drug compliance , may lead discontinuation drug . At time , risk treatment failure relapse high . Therefore monitor rate anti-TB drug induce adverse effect relate risk factor crucial . Awareness risk group may decrease incidence serious drug-related side effect medical cost . The fixed-dose combination ( FDCs ) tablets tuberculosis recommend WHO , simplify prescription drug prevent development drug resistance . However , FDC regimen consistent dosage usually give , high risk drug toxicity adverse reaction consider . To knowledge , report assess adverse effect FDC anti-TB drug Taiwan . The aim present study investigate current incidence side effect risk factor relate FDC drug side effect initial phase therapy .</brief_summary>
	<brief_title>The Incidence Risk Factors Side Effects During Initial Phase Rifater Therapy - Prospective Study</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>1 . Newly diagnose pulmonary TB extrapulmonary TB patient 2 . No previous antiTB drug treatment 3 . Age 18years old 1 . Expected life &lt; 6months 2 . Baseline AST ALT &gt; 3 fold upper limit normal ( ULN ) total bilirubin &gt; 2mg/dl 3 . Age le 18years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>